THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 2 filers reported holding THERAVANCE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $37,000 | -99.6% | 37,000 | -99.6% | 0.00% | -100.0% |
| Q3 2019 | $9,309,000 | -44.6% | 9,910,000 | -38.0% | 0.05% | -45.2% |
| Q2 2019 | $16,789,000 | +2.3% | 15,972,000 | -1.0% | 0.09% | -8.8% |
| Q1 2019 | $16,409,000 | -5.6% | 16,134,000 | -0.1% | 0.10% | -11.3% |
| Q4 2018 | $17,383,000 | +5.5% | 16,155,000 | -0.2% | 0.12% | +26.4% |
| Q3 2018 | $16,483,000 | +4.6% | 16,192,000 | -0.0% | 0.09% | -5.2% |
| Q2 2018 | $15,762,000 | -8.6% | 16,199,000 | +0.0% | 0.10% | -14.3% |
| Q1 2018 | $17,238,000 | +6.1% | 16,191,000 | -1.3% | 0.11% | +34.9% |
| Q4 2017 | $16,250,000 | +0.9% | 16,402,000 | -0.7% | 0.08% | -33.6% |
| Q3 2017 | $16,111,000 | +175.6% | 16,513,000 | +312.8% | 0.12% | +237.8% |
| Q4 2013 | $5,845,000 | -10.6% | 4,000,000 | 0.0% | 0.04% | -9.8% |
| Q3 2013 | $6,537,000 | +5.6% | 4,000,000 | 0.0% | 0.04% | +2.5% |
| Q2 2013 | $6,188,000 | – | 4,000,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 41,771 | $44,921,000 | 2.37% |
| LINDEN ADVISORS LP | 45,495,000 | $48,853,000 | 1.16% |
| BASSO CAPITAL MANAGEMENT, L.P. | 4,759,000 | $5,092,000 | 0.94% |
| SSI INVESTMENT MANAGEMENT LLC | 6,850,000 | $7,332,000 | 0.60% |
| TEALWOOD ASSET MANAGEMENT INC | 1,390,000 | $1,492,000 | 0.59% |
| Castle Creek Arbitrage, LLC | 6,070,000 | $6,516,000 | 0.48% |
| OAKTREE CAPITAL MANAGEMENT LP | 21,717,000 | $23,355,000 | 0.37% |
| AQR Arbitrage LLC | 27,018,000 | $29,055,000 | 0.34% |
| CSS LLC/IL | 5,000,000 | $5,360,000 | 0.27% |
| CQS Cayman LP | 4,150,000 | $4,469,000 | 0.21% |